Brain volume and dementia risk
Although the overall prevalence of dementia has been increasing along with population growth, the incidence of dementia, the number of new cases per year, has actually been decreasing in many parts of the world....
Author: Dan
An update on anti-amyloid therapies
My wife and I have just returned from a wonderful visit to Norway. I was quite taken by the legend of the trolls, the mischievous beasts that wreak havoc in the lives of country...
A Dutch language edition of A Tattoo on my Brain has just been released
Today I was interviewed for nearly 90 minutes by a reporter from the Flemish newspaper De Morgen for an upcoming book review of the Dutch language edition of A Tattoo on my Brain that was released last week....
Beach ghosts and donanemab
Yesterday evening as sundown approached, I looked out a window on the west side of our house and saw a startling headless reflection looking back enquiringly at me. The optics were easily explained: I...
Dispatches from the Land of Alzheimer’s was released today in the US
My second book, Dispatches from the Land of Alzheimer’s, was released today in the US by Cambridge University Press. It is a collection of essays about Alzheimer’s disease that I have written over the last few...
Keys Bags Names Words
On April 2, I will be participating in a panel discussion following a screening of the documentary film Keys Bags Names Words. This event will be held at 7 – 9 pm at the Smith Memorial...
CAA and ARIA revisited
Dr. Steven Greenberg is most likely the most knowledgeable expert in the world concerning cerebral amyloid angiopathy (CAA) and the vascular pathology associated with Alzheimer’s disease. Earlier this week, I had the honor of...
Excerpt from Dispatches From the Land of Alzheimer’s published yesterday in the Daily Mail
Yesterday the Daily Mail published an article based on my new book, Dispatches From the Land of Alzheimer’s. I think the Daily Mail editors did a really good job of organizing excerpts from the book...
Biogen gives up on aducanumab (Aduhelm)
On January 31, Biogen put out a press release indicating that it “plans to reprioritize its resources in Alzheimer’s disease” by halting development and marketing of the anti-amyloid monoclonal antibody aducanumab (Aduhelm). Patients currently...
Dispatches from the Land of Alzheimer’s is now available in the UK
As can be seen in this display window at the Cambridge University Press bookshop, my new book is now available in the UK and Europe. The book release date in the US is currently...
Recent Comments